MedPath

Impulsivity-focused group intervention to reduce binge eating episodes in patients with binge eating disorder

Not Applicable
Conditions
DSM-5: Binge Eating Disorder
F50.9
Eating disorder, unspecified
Registration Number
DRKS00007689
Lead Sponsor
niversitätsklinikum Tübingen, Innere Medizin VI, Psychosomatische Medizin und Psychotherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
86
Inclusion Criteria

diagnosis of Binge Eating Disorder according to DSM-5, age about 18, written and informed consent

Exclusion Criteria

1. current bulimia nervosa, current addictive disorders, psychotic disorders, bipolar I disorder, 2. current suicidality, 3. pregnancy, lactation, 4. somatic disorders influencing eating behaviour or weight with altered medication within the last three weeks, 5. current psychotherapeutic treatment of Binge Eating Disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The frequency of binge eating episodes within the last 4 weeks at T0 (at the beginning) and T1 (after 8 weeks (at the end of the training period)), assessed by Item 10 of the Eating Disorder Examaniation Interview (Hilbert & Tuschen-Caffier, 2004)
Secondary Outcome Measures
NameTimeMethod
Changes between T0 and T1 as well as T1 and T2 (3 months after end of the training period) concerning a) impulsivity: eyetracking variables assessing fodd-related and general impulsivity in the free exploration and antisaccade paradigms, BIS-15 and BIS/BAS questionnaires, b) psychopathology und impulsive eating behaviour by EDE, EDE-Q, BDI II, BMI (kg/m2), DEBQ, YFAS, FCQ-S and FCQ-T, c) Ratings of the valence of the used stimuli in the eye tracking paradigms. <br>Further, we analyse process questionnaires concerning binge eating episodes and impulsive behaviour, weekly assessed between T0 and T1, i.e. eight times<br>and an evaluation questionnaire concerning the impulsivity-focused behavioral modification programme.
© Copyright 2025. All Rights Reserved by MedPath